Prematurity Clinical Trial
Official title:
Effect of Target vs. Standard Human Milk Fortification on the Growth and Body Composition of Predominantly Human Milk Fed Very Preterm Infants
It is reported that the standard method for fortification of human milk (HM) overestimates the energy and protein densities of HM (Macedo MHNP 2018), thus originating infant undernutrition (Macedo AJP 2018). The target fortification, based on analysis of HM composition, is considered the gold-standard method (Rochow 2015, McLeod 2016). This observational mixed cohort study aims to assess if very preterm infants fed HM with target fortification have greater growth during hospital stay and better body composition at term post-menstrual age (PMA), than those fed HM with standard fortification.
Study design: observational mixed cohort study, comparing growth and body composition in a
contemporary cohort of very preterm infants fed HM with target fortification, the currently
adopted clinical practice, with a historical cohort of very preterm infants fed HM with
standard fortification (Macedo AJP 2018).
Study periods: historical cohort from 1 February 2014 to 28 February 2015; contemporary
cohort: start February 2020, estimated recruitment period of 16 months; Settings: Neonatal
Care Unit (NICU) and Human Milk Bank at Maternidade Dr. Alfredo da Costa and Nutrition
Laboratory at Hospital Dona Estefânia, Centro Hospitalar Universitário de Lisboa Central.
Product to be analyzed: HM, including mother's own milk (MOM) and donor's milk (DHM). Donor
HM is pasteurized using the Holder method (Peila 2016) which is adopted by the Human Milk
Bank of Maternidade Dr. Alfredo da Costa (Macedo MHNP 2018).
Demographic variables: Gestational age, sex, singleton or twin, birth weight, small-,
appropriate- or large-for-gestational age (<3rd percentile, ≥3rd percentile and ≤97th
percentile, >97th percentile, respectively) (Fenton 2013), severity index (SNAPPE II)
(Richardson 2001), use of prenatal corticosteroids, diagnosis of late sepsis (Modi 2009),
necrotizing enterocolitis (grade ≥ 3) (Bell 1971), intraperiventricular hemorrhage (grade ≥
3) (Papile 1978), multicystic periventricular leukomalacia (de Vries 1992), and chronic lung
disease (Becker 1984).
Method of collection and analysis of HM: as described in a previous study (Macedo MHNP 2018),
in order to minimize daily variability of breast milk composition, mothers are asked to save
milk collected through 24 hours in the same container. The HM composition (MOM and DHM) are
analyzed using the Miris human milk analyzer (Miris AB, Uppsala, Sweden), following the
method described in a previous study (Macedo MHNP 2018). The composition is expressed in
densities: Kcal/dL of energy and g/dl of fat, raw and true protein, carbohydrates and ashes.
Energy and macronutrient composition of the multi-component HM fortifier and modular protein
and fat supplements. For this purpose, an Excel program to calculate modular protein and fat
supplements to be added to fortified HM was developed and registered (Nona R, Cardoso M,
Portuguese Directorate of Intellectual Property Services, IGAC-DSPI, nº 480/2020, 26 February
2020).
Daily intakes of energy (Kcal/kg), protein (g/kg) and protein:energy ratio (P:E), based on
administered volume of milk (ml/kg).
Anthropometric and body composition measurements in infants: According to the previously
described method (Macedo AJP 2018), during the hospital stay, the same observer (MMC)
measures daily the body weight (allowing the calculation of weight gain velocity), and weekly
the length and the head circumference. Within the first week after discharge, body
composition will be assessed using displacement plethysmography, to evaluate fat mass (FM),
fat free mass (FFM), percentage of FM (%FM), percentage of FFM (%FFM) and FM index (FMI), as
described in a previous study (Macedo AJP 2018). Both FMI and %FM are used as indicators of
adiposity.
Estimate of sample size: The study sample size was calculated to detect a difference of 2
g/kg/day in growth velocity with a standard deviation 2.6 (Macedo, 2018; Tremblay, 2017) for
normally distributed variables, a significance level of 0.05, and an 80% power; thus, a
required sample of 67 infants (n1=33; n2+20%=34) was estimated.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03670732 -
CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure
|
N/A | |
Completed |
NCT05322161 -
Yoga in the NICU for Parents Study
|
N/A | |
Recruiting |
NCT04542096 -
Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
|
||
Recruiting |
NCT04911452 -
Creating a Calmer NICU: Optimizing Growth and Brain Development in Preterm Infants
|
N/A | |
Recruiting |
NCT02901652 -
NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome
|
N/A | |
Completed |
NCT02148965 -
Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial
|
N/A | |
Terminated |
NCT02032511 -
Comparison of RAM Cannula Nasal Continuous Positive Airway Pressure Versus Infant Flow Nasal Continuous Positive Airway Pressure (NCPAP)
|
N/A | |
Completed |
NCT02273843 -
A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset Sepsis
|
Phase 1 | |
Completed |
NCT01721629 -
Weaning of Nasal Continuous Positive Airway Pressure (CPAP) in Premature Infants
|
N/A | |
Terminated |
NCT01819532 -
Milking the Umbilical Cord Versus Immediate Clamping in Pre-term Infants < 33 Weeks
|
N/A | |
Completed |
NCT01523769 -
Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants
|
N/A | |
Completed |
NCT00951860 -
Assessment of Autonomic Maturation in Neonatal Period and Early Neural Development From a Longitudinal Prospective Cohort
|
N/A | |
Completed |
NCT01478711 -
Comprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants
|
N/A | |
Completed |
NCT00787124 -
Transfusions and Nitric Oxide Level in Preterm Infants
|
||
Completed |
NCT00749008 -
Study of Generalized Movements for Early Prediction of Cerebral Palsy
|
N/A | |
Completed |
NCT00527956 -
Facilitation and Barriers to Breastfeeding in the NICU
|
N/A | |
Terminated |
NCT00486395 -
Will CPAP Reduce Length Of Respiratory Support In Premature Infants?
|
Phase 3 | |
Terminated |
NCT01208493 -
Dietary Protein in the Very-low-birth-weight Infant
|
N/A | |
Completed |
NCT03372590 -
NEO Rehab for Infants at Risk of Cerebral Palsy
|
N/A | |
Completed |
NCT00033917 -
Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial
|
Phase 3 |